Minimizing Hypoglycemia While Maintaining Glycemic Control in Diabetes

In an accompanying Perspectives article, Cryer (1) identifies a number of different areas where therapeutic interventions have the potential to reduce hypoglycemia without compromising glycemic control. Some approaches provide well-defined clinical benefits, a few offer dramatic reductions in hypoglycemia but remain out of reach for most people, and others, although promising, have yet to be properly evaluated (Table 1). In this Perspectives article, I examine the evidence that underpins these interventions. It is beyond the scope of this article to review the data for each potential intervention in detail, but the reader is directed to the source where appropriate. The focus of this article is treatment of type 1 diabetes, as most of the specific potential therapies have been evaluated in this group, although included are comments in relation to recent trials of intensive therapy in type 2 diabetes. ### Education and skills training in self-management. Long before the benefits of tight glucose control had been established (2), the belief that insulin therapy should be designed to replace insulin “physiologically” had been advocated by a small number of enthusiastic clinicians. The advent of blood glucose monitoring in the late 1970s had a major impact, since background and meal-related insulin could be given separately and adjusted according to self-monitored blood glucose measurements. Participants were encouraged to eat freely, calculating their insulin dose according to their chosen amount of carbohydrate. Integrating these components was a complex task, probably beyond that of many physicians, let alone patients. If this was to be undertaken every day, then patients needed to acquire the skill of flexible insulin self-management and apply it successfully. The therapeutic education approach was pioneered by Assal et al. (3), and Berger and Muhlhauser (4) went on to develop a residential training course (Insulin Treatment and Training program [ITTP]) evaluating the intervention in a series of studies, including …

[1]  S. Schinner,et al.  Effects of Intensive Glucose Lowering in Type 2 Diabetes , 2009 .

[2]  S. Schinner Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes , 2009 .

[3]  P. Cryer The Barrier of Hypoglycemia in Diabetes , 2008, Diabetes.

[4]  A. Ertl,et al.  Effects of a Selective Serotonin Reuptake Inhibitor, Fluoxetine, on Counterregulatory Responses to Hypoglycemia in Healthy Individuals , 2008, Diabetes.

[5]  Roman Hovorka,et al.  The future of continuous glucose monitoring: closed loop. , 2008, Current diabetes reviews.

[6]  L. Thabane,et al.  The effect of continuous subcutaneous glucose monitoring (CGMS) versus intermittent whole blood finger-stick glucose monitoring (SBGM) on hemoglobin A1c (HBA1c) levels in Type I diabetic patients: a systematic review. , 2008, Diabetes research and clinical practice.

[7]  Hui Tang,et al.  Modafinil modulates GABA-activated currents in rat hippocampal pyramidal neurons , 2008, Brain Research.

[8]  A. Berghold,et al.  Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis , 2008, Diabetologia.

[9]  R. Gerard Continuous glucose monitoring and diabetes health outcomes: a critical appraisal. , 2008 .

[10]  G. Reach Continuous glucose monitoring and diabetes health outcomes: a critical appraisal. , 2008, Diabetes technology & therapeutics.

[11]  R. M. Meloche Transplantation for the treatment of type 1 diabetes. , 2007, World journal of gastroenterology.

[12]  I M E Wentholt,et al.  Continuous glucose monitors: the long-awaited watch dogs? , 2007, Diabetes technology & therapeutics.

[13]  G. Guyatt,et al.  Patient-important outcomes in diabetes—time for consensus , 2007, The Lancet.

[14]  A. Berghold,et al.  Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus. , 2007, The Cochrane database of systematic reviews.

[15]  R. Sherwin,et al.  ATP-Sensitive K+ Channels Regulate the Release of GABA in the Ventromedial Hypothalamus During Hypoglycemia , 2007, Diabetes.

[16]  E Renard,et al.  Implantable insulin pumps. A position statement about their clinical use. , 2007, Diabetes & metabolism.

[17]  P. Lucidi,et al.  Effect of the amino acid alanine on glucagon secretion in non-diabetic and type 1 diabetic subjects during hyperinsulinaemic euglycaemia, hypoglycaemia and post-hypoglycaemic hyperglycaemia , 2007, Diabetologia.

[18]  Philippe Morel,et al.  International trial of the Edmonton protocol for islet transplantation. , 2006, The New England journal of medicine.

[19]  P. Cryer,et al.  Nocturnal hypoglycemia in type 1 diabetes: an assessment of preventive bedtime treatments. , 2006, The Journal of clinical endocrinology and metabolism.

[20]  J. Pickup,et al.  Are insulin pumps underutilized in type 1 diabetes? Yes. , 2006, Diabetes care.

[21]  S. Heller,et al.  Improved glycaemic control with insulin glargine plus insulin lispro: a multicentre, randomized, cross‐over trial in people with Type 1 diabetes , 2006, Diabetic medicine : a journal of the British Diabetic Association.

[22]  R. Sherwin,et al.  Activation of ATP-sensitive K+ channels in the ventromedial hypothalamus amplifies counterregulatory hormone responses to hypoglycemia in normal and recurrently hypoglycemic rats. , 2005, Diabetes.

[23]  I. Mühlhauser,et al.  Glycaemic control and severe hypoglycaemia following training in flexible, intensive insulin therapy to enable dietary freedom in people with type 1 diabetes: a prospective implementation study , 2005, Diabetologia.

[24]  Jacqueline Ryder,et al.  Influence of caffeine on frequency of hypoglycemia detected by continuous interstitial glucose monitoring system in patients with long-standing type 1 diabetes. , 2005, Diabetes care.

[25]  P. Cryer,et al.  Loss of the decrement in intraislet insulin plausibly explains loss of the glucagon response to hypoglycemia in insulin-deficient diabetes: documentation of the intraislet insulin hypothesis in humans. , 2005, Diabetes.

[26]  T R Pieber,et al.  Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus. , 2006, The Cochrane database of systematic reviews.

[27]  I. Macdonald,et al.  The effect of modafinil on counter-regulatory and cognitive responses to hypoglycaemia , 2004, Diabetologia.

[28]  R. Sherwin,et al.  Hypothalamic ATP-sensitive K + channels play a key role in sensing hypoglycemia and triggering counterregulatory epinephrine and glucagon responses. , 2004, Diabetes.

[29]  N. Waugh,et al.  Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes. , 2004, Health technology assessment.

[30]  J. Plank,et al.  Long-term evaluation of a structured outpatient education programme for intensified insulin therapy in patients with Type 1 diabetes: a 12-year follow-up , 2004, Diabetologia.

[31]  S. Colagiuri,et al.  Hypoglycaemia with insulin aspart: a double‐blind, randomised, crossover trial in subjects with Type 1 diabetes , 2004, Diabetic medicine : a journal of the British Diabetic Association.

[32]  Bruce A Buckingham,et al.  Lack of accuracy of continuous glucose sensors in healthy, nondiabetic children: results of the Diabetes Research in Children Network (DirecNet) accuracy study. , 2004, The Journal of pediatrics.

[33]  K. Hermansen,et al.  Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with Type 1 diabetes , 2004, Diabetologia.

[34]  I. Mühlhauser,et al.  Patient education as the basis for diabetes care in clinical practice and research , 1985, Diabetologia.

[35]  C. Tack,et al.  Effect of 2 Weeks of Theophylline on Glucose Counterregulation in Patients with Type 1 Diabetes and Unawareness of Hypoglycemia , 2003, Clinical pharmacology and therapeutics.

[36]  S. Amiel,et al.  The effects of KATP channel modulators on counterregulatory responses and cognitive function during acute controlled hypoglycaemia in healthy men: a pilot study , 2003, Diabetic medicine : a journal of the British Diabetic Association.

[37]  I. Mühlhauser,et al.  Patient education – evaluation of a complex intervention , 2002, Diabetologia.

[38]  Aaron B. Neinstein,et al.  Nocturnal hypoglycemia detected with the Continuous Glucose Monitoring System in pediatric patients with type 1 diabetes. , 2002, The Journal of pediatrics.

[39]  A. Moran,et al.  Spurious reporting of nocturnal hypoglycemia by CGMS in patients with tightly controlled type 1 diabetes. , 2002, Diabetes care.

[40]  J. Pasman,et al.  Theophylline improves hypoglycemia unawareness in type 1 diabetes. , 2002, Diabetes.

[41]  B. Zinman,et al.  Insulins today and beyond , 2001, The Lancet.

[42]  D. Cox,et al.  Blood glucose awareness training (BGAT-2): long-term benefits. , 2001, Diabetes care.

[43]  M. Lunt,et al.  Influence of caffeine on the frequency and perception of hypoglycemia in free-living patients with type 1 diabetes. , 2000, Diabetes care.

[44]  M. Quigley,et al.  Blood glucose awareness training and epinephrine responses to hypoglycemia during intensive treatment in type 1 diabetes. , 1999, Diabetes care.

[45]  P. Cryer,et al.  Durable reversal of hypoglycemia unawareness in type 1 diabetes. , 1999, Diabetes care.

[46]  F. Holleman,et al.  Reduced Frequency of Severe Hypoglycemia and Coma in Well-Controlled IDDM Patients Treated With Insulin Lispro , 1997, Diabetes Care.

[47]  P. Cryer,et al.  Alanine and Terbutaline in the Prevention of Nocturnal Hypoglycemia in IDDM , 1997, Diabetes Care.

[48]  I. Mühlhauser,et al.  Intensified insulin therapy and the risk of severe hypoglycaemia , 1997, Diabetologia.

[49]  D. Cox,et al.  A Multicenter Evaluation of Blood Glucose Awareness Training-II , 1995, Diabetes Care.

[50]  P. Cryer,et al.  Reversal of Hypoglycemia Unawareness, But Not Defective Glucose Counterregulation, in IDDM , 1994, Diabetes.

[51]  A. Maran,et al.  Restoration of hypoglycaemia awareness in patients with long-duration insulin-dependent diabetes , 1994, The Lancet.

[52]  Paolo Brunetti,et al.  Meticulous Prevention of Hypoglycemia Normalizes the Glycemic Thresholds and Magnitude of Most of Neuroendocrine Responses to, Symptoms of, and Cognitive Function During Hypoglycemia in Intensively Treated Patients With Short-Term IDDM , 1993, Diabetes.

[53]  W. Tamborlane,et al.  Effect of Caffeine on the Recognition of and Responses to Hypoglycemia in Humans , 1993, Annals of Internal Medicine.

[54]  S. Genuth,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[55]  H. Imura,et al.  Lymphocytic infundibuloneurohypophysitis as a cause of central diabetes insipidus. , 1993, The New England journal of medicine.

[56]  P. Cryer,et al.  Induction of Hypoglycemia Unawareness by Asymptomatic Nocturnal Hypoglycemia , 1993, Diabetes.

[57]  I. Mühlhauser,et al.  Diabetes education and insulin therapy: when will they ever learn? , 1993, Journal of internal medicine.

[58]  J. Brange,et al.  Monomeric insulins obtained by protein engineering and their medical implications , 1988, Nature.

[59]  S. Colagiuri,et al.  The Diabetes Control and Complications Trial , 1983, Henry Ford Hospital medical journal.